E

Everest Medicines Ltd
HKEX:1952

Watchlist Manager
Everest Medicines Ltd
HKEX:1952
Watchlist
Price: 44.66 HKD -3.29% Market Closed
Market Cap: 15.8B HKD

Intrinsic Value

The intrinsic value of one Everest Medicines Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 44.66 HKD, Everest Medicines Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Everest Medicines Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Everest Medicines Ltd

Intrinsic Value History
Dive into the past to invest in the future

Everest Medicines Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Everest Medicines Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Everest Medicines Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Everest Medicines Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Everest Medicines Ltd.

Explain Valuation
Compare Everest Medicines Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Everest Medicines Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Everest Medicines Ltd

Current Assets 2.3B
Cash & Short-Term Investments 1.9B
Receivables 293.6m
Other Current Assets 35.2m
Non-Current Assets 2.9B
Long-Term Investments 44.9m
PP&E 679.4m
Intangibles 2.2B
Other Non-Current Assets 8.1m
Current Liabilities 481.5m
Accounts Payable 70.3m
Accrued Liabilities 51.7m
Other Current Liabilities 359.6m
Non-Current Liabilities 284.2m
Long-Term Debt 278.3m
Other Non-Current Liabilities 6m
Efficiency

Free Cash Flow Analysis
Everest Medicines Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Everest Medicines Ltd

Revenue
851.3m CNY
Cost of Revenue
-256.1m CNY
Gross Profit
595.2m CNY
Operating Expenses
-1.3B CNY
Operating Income
-726.2m CNY
Other Expenses
67.4m CNY
Net Income
-658.8m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Everest Medicines Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
hidden
Profitability
Score

Everest Medicines Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Everest Medicines Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Everest Medicines Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Everest Medicines Ltd

Wall Street analysts forecast Everest Medicines Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Everest Medicines Ltd is 71.53 HKD with a low forecast of 55.55 HKD and a high forecast of 92.4 HKD.

Lowest
Price Target
55.55 HKD
24% Upside
Average
Price Target
71.53 HKD
60% Upside
Highest
Price Target
92.4 HKD
107% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Everest Medicines Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Everest Medicines Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Everest Medicines Ltd stock?

The intrinsic value of one Everest Medicines Ltd stock under the Base Case scenario is hidden HKD.

Is Everest Medicines Ltd stock undervalued or overvalued?

Compared to the current market price of 44.66 HKD, Everest Medicines Ltd is hidden .

Back to Top